drug

GEN1055

1 story · latest Aug 11, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Genmab A/S

Timeline

Genmab terminates Phase 1/2 GEN1055 trial for strategic reasons; results now posted

Aug 11Trial updateBioNTech SE GEN1055

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.